Facilities

R & D

To meet the challenges of the ever-changing and developing world, Orchev has since the beginning given the emphasis on R&D.  Our main focus remains on improving processes to obtain excellent quality material, Maximum yield, minimize pollution, and less energy & water requirement. Since September 2014, Orchev took the next step in its growth by setting up a separate R&D team.…

Read more

Pollution Control

ORCHEV respects the environment and takes every possible steps to protect it. The whole plant is in retention for the liquid raw materials arrival as well as for the departure of the liquid wastes. We have, to our credit, an effluent treatment plant (ETP), one of the largest of its kind in Western Gujarat. Stringent measures are adopted to ensure…

Read more

Packing and Storage

Our products are sold to the local market as well as to more than 55 countries worldwide, to countries as far as LATAM, where transit time is around 50 days by SEA. Thus packing for export is crucial and we take utmost care.  Each product is packed as per its nature and requirement during transport.  APIs are packed in HM…

Read more

Powder Processing Area

We have experience of handling highly hygroscopic Ranitidien which has to be handled with utmost care. Crystallization of API and dry powder processing area is under controlled environment class 10000 (ISO class 7 – Grade C). Our crystallization area equipped with GMP model glass line reactor & GMP model 4P centrifuges. Our dry powder processing department equipped with Roto Cone…

Read more

Production

Production

The facility spread over an area of 16187 sq.m with 3966.46 sq.m built-up area.  At each stage of manufacturing, utmost care is taken to ensure perfect quality. The production unit is equipped with S.S. 316 Reactors ranging from 500 to 6000 Ltrs. capacity, Glass line Vessels ranging from 500 to 3000 ltrs capacity, S.S. 316 Centrifuges, S.S. 316 Sparkler filters,…

Read more

Regulatory Approvals

Orchev Pharma Pvt. Ltd. is involved in the process of manufacturing quality Active Pharma Ingredients in accordance with GMP, USFDA and ICH Q7 guidelines. Our plant located at Rajkot is manufacturing. The plant has the following regulatory approvals for Ranitidine: 1) USFDA [August 2018] 2) EU-GMP (AEMPS – Spain) [June 15] 3) EDQM – COS [June 15] 4) WHO –…

Read more